The type I interferon, interferon-α (IFNα), is expressed in islets of T1D patients5, and antibodies neutralizing different isoforms of IFNα prevent T1D development in individuals with polyglandular autoimmune syndrome type 16. This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.